Background : Left main coronary artery (LMCA) compression is increasingly recognized as a
cause of angina in pulmonary arterial hypertension (PAH). Objectives : This study aimed to …

Aims Pulmonary hypertension ( PH ) is a relevant complication of left heart disease ( LHD ).
The 2015 ESC / ERS PH guidelines report two different haemodynamic subsets of PH due to …

Pulmonary arterial hypertension is a severe disease with a complex pathogenesis, for
which combination therapy is an attractive option. This study aimed to assess the impact of …

Background Pulmonary endarterectomy (PEA) has been the most effective therapy for
chronic thromboembolic pulmonary hypertension (CTEPH). However, there is a substantial …

The combination of an initial clinical approach aimed at evaluating the early risk of mortality
with subsequent diagnostic and therapeutic approaches articulated on the overall patient’s …

Pulmonary arterial hypertension (PAH) is a severe clinical condition defined as mean
pulmonary artery pressure≥ 25 mmHg and normal pulmonary capillary wedge pressure (≤ 15 …

Patients with pulmonary arterial hypertension (PAH) often complain of chest pain or angina
pectoris in the absence of coronary artery disease. In this patients’ subgroup, we reported the …

Background The primary objective of this post hoc analysis was to evaluate clinical
outcomes of tadalafil in patients with pulmonary arterial hypertension (PAH) associated with …

L’ipertensione arteriosa polmonare (IAP) è una severa condizione clinica caratterizzata dal
punto di vista emodinamico da valori di pressione arteriosa polmonare media ≥25 mmHg e …

Background: Pulmonary endarterectomy (PEA) is the gold standard therapy for chronic
thromboembolic pulmonary hypertension (CTEPH). Traditionally, pulmonary vascular resistance (…